AD-057.4

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAD-057.4
Drug Alias NameApo2L/TRAIL protein (Adamed)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionTNF-related apoptosis-inducing ligand receptors agonists
TargetsTNF-related apoptosis-inducing ligand receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdamed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdamed
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A